International Journal of Membrane Science and Technology (Volume 9 Issue 1) | |
Cell-derived Giant Membrane Vesicles Enclosing the Anthracycline Anti-Cancer Drug Doxorubicin and their Cytotoxicity | ![]() |
Pages 13-19 Saya Okada and Hisato Saitoh DOI: https://doi.org/10.15379/2410-1869.2022.09.01.02 Published: 25 June 2022 |
|
Abstract | |
Although giant membrane vesicles prepared from paraformaldehyde-treated mammalian cells have been used to elucidate lipid and protein dynamics on the cell surface, there are few studies that have used them as a tool to deliver drugs to cells. Here we found that anti-cancer drug doxorubicin (Dox) was efficiently incorporated into and stably retained in giant membrane vesicles prepared from HeLa human cervical cancer cells. Intriguingly, coincubation of Dox-enclosed giant membrane vesicles with human pancreatic cancer-derived PK-59 and gastric cancer-derived KE-39 cells led to cell death. Microscopic observation of vesicle-docked cells revealed that docking of at least one to a few Dox-enclosed giant vesicles on the cellular cortex was sufficient to induce cell death, suggesting applicability of cell-derived giant membrane vesicles as an efficient drug delivery vector in cultured cell systems. |
|
Keywords | |
Anti-cancer treatment, Extracellular vesicle, Doxorubicin, Drug delivery.
|
|
![]() |